Development of mini-SSPedi for children 4–7 years of age receiving cancer treatments
Abstract Background The Symptom Screening in Pediatrics Tool (SSPedi) is valid for assessing symptoms in children aged 8–18 years receiving cancer treatments. The objective was to develop a new self-report symptom screening tool for children receiving cancer treatments who are 4–7 years of age (mini...
Main Authors: | Deborah Tomlinson, Shannon Hyslop, Eliana Stein, Brenda Spiegler, Emily Vettese, Susan Kuczynski, Tal Schechter, L. Lee Dupuis, Lillian Sung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5210-z |
Similar Items
-
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments
by: Dupuis, L.L, et al.
Published: (2022) -
Discordance between pediatric self‐report and parent proxy‐report symptom scores and creation of a dyad symptom screening tool (co‐SSPedi)
by: Deborah Tomlinson, et al.
Published: (2020-08-01) -
Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application
by: Emily Vettese, et al.
Published: (2019-05-01) -
Initial development of Supportive care Assessment, Prioritization and Recommendations for Kids (SPARK), a symptom screening and management application
by: Sadie Cook, et al.
Published: (2019-01-01) -
Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatments
by: Cody Z. Watling, et al.
Published: (2020-09-01)